Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Ivan Staikov

Showing results (1-10 of 8) with videos related to

Pageof 1
Sort By:
Clinics in Dermatology|April 29, 2014
Herpes zoster as a systemic diseaseIvan Staikov, Neyko Neykov, Branka Marinovic, et al.
Psychiatry Research|September 5, 2002
Temporal modulation of cerebral hemodynamics under prefrontal challenge in schizophrenia: a transcranial Doppler sonography studyDaniel Schuepbach, Friedrich Goenner, Ivan Staikov, et al.
Arzneimittel-Forschung|April 19, 2006
Bioequivalence of a novel high-dose oral formulation of alpha-dihydroergocryptineChristian de Mey, Paraskeva Stamenova, Marin Daskalov, et al.
European Stroke Journal|April 23, 2019
European Stroke Organisation certification of stroke units and stroke centresUlrike Waje-Andreassen, Darius G Nabavi, Stefan T Engelter, et al.
The New England Journal of Medicine|February 14, 2024
Inhibition of CD40L with Frexalimab in Multiple SclerosisPatrick Vermersch, Cristina Granziera, Yang Mao-Draayer, et al.
The New England Journal of Medicine|May 11, 2019
Placebo-Controlled Trial of an Oral BTK Inhibitor in Multiple SclerosisXavier Montalban, Douglas L Arnold, Martin S Weber, et al.
European Stroke Journal|January 30, 2026
Rationale, design and baseline characteristics of participants in the OCEANIC-STROKE trial of FXIa inhibition for secondary stroke preventionMukul Sharma, Qiang Dong, Teruyuki Hirano, et al.
The New England Journal of Medicine|April 15, 2026
Asundexian for Secondary Stroke PreventionMukul Sharma, Qiang Dong, Teruyuki Hirano, et al.
Pageof 1

Showing results (1-10 of 8) with videos related to

Sort By:
Pageof 1
Clinics in Dermatology|April 29, 2014
Herpes zoster as a systemic diseaseIvan Staikov, Neyko Neykov, Branka Marinovic, et al.
Psychiatry Research|September 5, 2002
Temporal modulation of cerebral hemodynamics under prefrontal challenge in schizophrenia: a transcranial Doppler sonography studyDaniel Schuepbach, Friedrich Goenner, Ivan Staikov, et al.
Arzneimittel-Forschung|April 19, 2006
Bioequivalence of a novel high-dose oral formulation of alpha-dihydroergocryptineChristian de Mey, Paraskeva Stamenova, Marin Daskalov, et al.
European Stroke Journal|April 23, 2019
European Stroke Organisation certification of stroke units and stroke centresUlrike Waje-Andreassen, Darius G Nabavi, Stefan T Engelter, et al.
The New England Journal of Medicine|February 14, 2024
Inhibition of CD40L with Frexalimab in Multiple SclerosisPatrick Vermersch, Cristina Granziera, Yang Mao-Draayer, et al.
The New England Journal of Medicine|May 11, 2019
Placebo-Controlled Trial of an Oral BTK Inhibitor in Multiple SclerosisXavier Montalban, Douglas L Arnold, Martin S Weber, et al.
European Stroke Journal|January 30, 2026
Rationale, design and baseline characteristics of participants in the OCEANIC-STROKE trial of FXIa inhibition for secondary stroke preventionMukul Sharma, Qiang Dong, Teruyuki Hirano, et al.
The New England Journal of Medicine|April 15, 2026
Asundexian for Secondary Stroke PreventionMukul Sharma, Qiang Dong, Teruyuki Hirano, et al.
Pageof 1